Docusign, INC Form 4 insider transactions

NASDAQ
Docusign President and CEO Allan Thygesen reported transactions involving the sale of company stock, executed under a Rule 10b5-1 trading plan.
NASDAQ
DocuSign President Robert Chatwani reported the vesting of restricted and performance stock units and subsequent tax-related share withholding.
NASDAQ
DocuSign CEO Allan Thygesen acquired 65,561 shares through the vesting of restricted and performance stock units, with a portion withheld for taxes.
NASDAQ
DocuSign Chief Revenue Officer Paula Hansen reported the acquisition and vesting of common stock and equity awards.
NASDAQ
DocuSign Chief Legal Officer James P. Shaughnessy acquired 20,972 shares through the vesting of restricted and performance stock units.
NASDAQ
DocuSign CFO Blake Grayson acquired shares through RSU/PSU vesting and ESPP participation, with a portion withheld for taxes.
NASDAQ
DocuSign Director Brian Roberts acquired 855 shares of common stock through the vesting of restricted stock units.
NASDAQ
Director Anna Marrs acquired 725 shares of DocuSign common stock via RSU vesting and subsequently sold 363 shares.
NASDAQ
Director Michael Rosenbaum acquired 522 shares of DocuSign common stock through the vesting of restricted stock units.
NASDAQ
Director Enrique Salem acquired 729 shares of DocuSign common stock via RSU vesting and was granted 4,384 new restricted stock units.
NASDAQ
Director Teresa Briggs acquired and sold DocuSign common stock following the vesting of restricted stock units.
NASDAQ
Director Mary Wilderotter reported a transfer of shares to a family trust and the acquisition of restricted stock units.
NASDAQ
Director Peter Solvik exercised restricted stock units and received a new grant of equity in DocuSign, Inc.
NASDAQ
Director Cain Hayes acquired 729 shares of DocuSign common stock through RSU vesting and was granted 4,384 additional RSUs.
NASDAQ
Director Blake Irving acquired 729 shares of DocuSign common stock through the vesting of restricted stock units and was granted 4,384 new RSUs.
NASDAQ
DocuSign Director James Beer reported the vesting of restricted stock units and a subsequent sale of common stock.
NASDAQ
Director Anna Marrs exercised restricted stock units and sold a portion of shares to cover tax obligations under a 10b5-1 plan.
NASDAQ
Director Rowan Trollope was granted 10,438 restricted stock units as part of DocuSign's equity compensation program.
NASDAQ
DocuSign Director Mary Agnes Wilderotter acquired and disposed of company shares on April 1, 2026, according to a Form 4 filing.
NASDAQ
DocuSign's Chief Revenue Officer, Paula Hansen, executed a series of stock sales totaling 5,900 shares under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Docusign's Chief Legal Officer, James P. Shaughnessy, executed a series of stock sales totaling 11,999 shares under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Docusign President and CEO Allan Thygesen has sold a significant number of company shares through a pre-arranged trading plan.
NASDAQ
DocuSign Director Brian Keith Roberts was granted 10,269 Restricted Stock Units, vesting quarterly over three years starting March 5, 2026.
NASDAQ
DocuSign's President General Manager of Growth, Robert Chatwani, sold 16,696 shares of common stock on March 18, 2026, through a pre-arranged 10b5-1 trading plan.
NASDAQ
DocuSign's President General Manager, Growth, Robert Chatwani, reported the vesting of restricted and performance stock units and related tax-driven share disposals.
NASDAQ
DocuSign CEO Allan C. Thygesen reported the vesting of restricted and performance stock units and subsequent tax-related share disposals on March 15, 2026.
NASDAQ
DocuSign's Chief Revenue Officer, Paula Hansen, filed a Form 4 detailing future equity transactions, including RSU and PSU vesting and tax-related share disposals.
NASDAQ
DocuSign's Chief Legal Officer, James P. Shaughnessy, reported the vesting of restricted and performance stock units and related tax-driven share withholding.
NASDAQ
DocuSign CFO Blake Jeffrey Grayson reported the vesting and tax-related disposition of common stock and derivative securities on March 15, 2026.
NASDAQ
DocuSign Director Anna Marrs reported the vesting of 725 restricted stock units and the subsequent sale of 363 common shares under a pre-arranged trading plan.